Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) EBT Margin (2020 - 2025)

Biofrontera has reported EBT Margin over the past 6 years, most recently at 32.98% for Q4 2025.

  • For Q4 2025, EBT Margin rose 4412.0% year-over-year to 32.98%; the TTM value through Dec 2025 reached 25.2%, up 2233.0%, while the annual FY2025 figure was 25.2%, 2232.0% up from the prior year.
  • EBT Margin for Q4 2025 was 32.98% at Biofrontera, up from 95.06% in the prior quarter.
  • Over five years, EBT Margin peaked at 57.34% in Q1 2022 and troughed at 369.31% in Q3 2021.
  • A 5-year average of 69.13% and a median of 60.56% in 2022 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: tumbled -27940bps in 2021 and later soared 30996bps in 2022.
  • Year by year, EBT Margin stood at 158.16% in 2021, then surged by 83bps to 27.44% in 2022, then soared by 221bps to 33.22% in 2023, then crashed by -134bps to 11.14% in 2024, then surged by 396bps to 32.98% in 2025.
  • Business Quant data shows EBT Margin for BFRI at 32.98% in Q4 2025, 95.06% in Q3 2025, and 58.73% in Q2 2025.